Is the U.S. Marshal Service a Racketeering Influenced Organization?

Sounds like a preposterous question, doesn't it? But not so fast. Oddly enough, on the very day the U.S. Marshal Service adamantly refused my request that it refer to the FBI for investigation my fraudulent Social Security and Medicare scheme, the media reported that the White House was planning a major investment in uncovering Medicare fraud.

Some background: On Friday January 15, 2010 I was interviewed at my residence by the U.S. Marshal Service concerning a law enforcement matter. I told the Marshals that my Social Security disability claim was a "total fraud." When I asked the Marshals to refer my case to the FBI for investigation, they refused. One of the Marshals said that the kind of fraud I was alleging was probably too difficult for the FBI to investigate. He explained that it was difficult to pierce the veil of a patient's clinical record and question the clinical observations and conclusions of a psychiatrist.

In fact, the FBI routinely investigates Social Security and Medicare fraud by piercing the veil of a patient's clinical record.

Apparently, the U.S. Marshal Service lied. But why? Is the U.S. Marshal Service a racketeering influenced organization? Is it the policy of the U.S. Marshal Service to turn a blind eye to fraud schemes against the federal government? Has the U.S. Marshal Service been infiltrated by organized crime? In this connection it is interesting to note that a senior management partner of the law firm of Akin, Gump Strauss, Hauer & Feld -- a firm about which I have formed a good faith belief is a racketeering influenced organization, according to the D.C. Attorney General -- has close ties to the highest levels of the U.S. Department of Justice. That same partner tried to buy the silence of a White House intern, reportedly, in the late 1990s to protect former President Bill Clinton.

Then, there's the case of former Wisconsin Governor Tommy Thompson, former Secretary of the Department of Health and Human Services -- the parent Department of the Social Security Administration. Governor Thompson has himself been linked to an alleged pack of racketeers: the Monsanto Corporation. You know what Governor Thompson is doing now? He practices law at the firm of Akin, Gump, Strauss, Hauer & Feld.

On the very day the U.S. Marshal Service advised me that it could not refer my Social Security Claim for criminal investigation -- Friday January 15, 2010 -- the Psychiatric News published the following story announcing a major crackdown on fraud, waste, and abuse of federal health care benefits programs by the federal government. Peculiar isn't it? I have never heard of the U.S. Marshal Service turning a blind eye to the commission of a felony, in this case one that will eventually lead to the federal government being defrauded of a half million dollars.

The D.C. Office of Attorney General, in legal proceedings before two Courts, in two separate legal proceedings, affirmed that I formed a genuine, good-faith belief that the law firm of Akin, Gump, Strauss, Hauer & Feld, has committed acts that might constitute the crime of racketeering under federal law. And yet, the Justice Department refuses to investigate this felony. This case has been screaming for attention for years. Yet, the Justice Department will not investigate.

I ask again: Is the U.S. Marshal Service the passive dupe of a fraud and racketeering conspiracy being carried out by one of the largest law firms in the world?

White House Plans Major Investment in Uncovering Medicare Fraud

Rich Daly
Psychiatric News
January 15, 2010

Several government efforts are trying to get control of runaway fraudulent activity in federal health programs, but critics question whether such efforts will produce any significant reduction in this costly problem.

Faced with Medicaid and Medicare fraud that could eventually match or exceed the cost of the massive health care reforms it is considering, Congress is weighing efforts to address the problem at the same time it is debating future expansion of those two programs. But critics view the fraud-fighting campaign as unlikely to staunch a problem that threatens to upend the federal entitlement system.

The fraud issue has drawn growing attention during the health care reform debate amid findings that fraudulent claims already account for a significant portion of federal health care spending.

Medicare and Medicaid spending was estimated to have reached at least $818 billion in 2008, according to a February 2009 Health Affairs report. Meanwhile, the federal government estimates that at least $65 billion of that spending is taken by fraud, and private researchers estimate the fraud loss as high as $100 billion in 2008. Such estimates would establish the cost of fraud as equal to, or greater than, the 10-year cost of the health care reform proposals under consideration in Congress.

Health care reform bills in Congress contain provisions that aim to strengthen the federal antifraud effort. Those provisions have been derided by some activists as inadequate to address the problem. For example, the nation's chief health care actuary estimated in November 2009 that the House health care bill (HR 3962) would cut Medicare and Medicaid fraud by $60 million annually. The antifraud provisions in the Senate bill (HR 3590) are predicted to cut only $2 billion of fraud from Medicare and Medicaid over 10 years. Both of these barely make a dent in the problem.

Some congressional critics of expanding the number of Americans eligible for federal health programs maintain that private insurers are more focused on and do a much better job of rooting out fraud, devoting a larger proportion of their administrative costs to identifying such fraud.

Antifraud Efforts Lead to Indictments

Federal prosecutors have announced a growing list of indictments and settlements for fraud under Medicare and Medicaid in recent years. A prominent example was a $22.5 million settlement by Eli Lilly and Co. over allegations it defrauded Medicaid by improperly marketing the atypical antipsychotic drug Zyprexa.

Fraud by drug makers is, however, just one category of fraud tracked by federal investigators; other key targets include fraud by clinicians, health care facilities, and medical-equipment suppliers. Antifraud activists generally believe that clinicians are the most common perpetrators of health care fraud, because they have the widest access to patient information used in submitting insurance claims.

Although numerous examples of proven fraud in each category are publicized by federal investigators, no statistics exist to illustrate how much fraud has been found in any one category, a spokesman for the Department of Health and Human Services (HHS) told Psychiatric News.

The challenge of combating fraud in federal health care programs is huge, with Medicare alone receiving 4.4 million claims each day. A new Medicare antifraud task force is able to review only 3 percent of those claims, according to congressional testimony by William Corr, deputy secretary of HHS.

Increasingly, antifraud efforts have had some success, with investigations by the HHS inspector general's office resulting in collection of $4 billion in Fiscal 2009, which was an increase from $3.2 billion in Fiscal 2008.

The Obama administration also is considering a summit that would bring together patients, physicians, insurers, and law-enforcement officials to brainstorm ways to identify and combat fraud in Medicare and Medicaid, according to Corr.

The Obama administration also looks to combat fraud through increased funding. The president's Fiscal 2010 budget would invest $311 million, or 50 percent more than the previous fiscal year, to boost antifraud efforts in Medicare and Medicaid. Those efforts would likely cut fraud in those public insurance programs by $2.7 billion over five years, according to Justice Department estimates.

Fraud-Fighting Bills Introduced

Beyond the health care bill, several legislative efforts address Medicare and Medicaid fraud.

Legislation to reduce the growing burden of fraud in Medicare and Medicaid include the Seniors and Taxpayers Obligation Protection Act (S 975), introduced by Sen. Mel Martinez (R-Fla.) last May, which would create fraud prevention and detection systems in the Centers for Medicare and Medicaid Services. The legislation aims to provide the tools and authority to prevent fraud before it starts, which is the point in the process when experts say antifraud efforts are most likely to succeed.

“While the vast majority of health care providers are honest and caring professionals, it is simply unacceptable that there still are people who are willing to scam the system and take advantage of some of our nation's most vulnerable citizens,” said Sen. Susan Collins (R-Maine), a cosponsor of the bill.

Other antifraud legislation includes a bill sponsored by Sen. Ted Kaufman (D-Del.) to lengthen prison sentences for health care fraud and give government fraud fighters $20 million more annually through 2016.

“We all know that rooting out waste, fraud, and abuse, in both government and private programs, is critical to making health care reform work,” Kaufman said, about the Health Care Fraud Enforcement Act.